Skip to main content

Carolina Campos Martinez

Predoctoral Researcher at the Liver Diseases - Viral Hepatitis Research group. Bachelor's degree in Biotechnology and MSc in Translational Biomedical Research by the Vall d'Hebron Institute of Research Fundation. Currently working as a PhD Student at the Liver diseases-Viral hepatitis research group and studying at the PhD program of Biochemistry, Molecular Biology and Biomedicine of Universitat Autònoma de Barcelona. My studies are focused on the evolution of viral quasispecies of SARS-CoV-2 in the most prevalent variants in Barcelona city over the pandemics, thanks to next generation sequencing (MiSeq and Nextseq2000 Illumina platforms), and how these viral quasispecies are involved with clinical and epidemiological purposes.

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Carolina Campos Martinez

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Predoctoral Researcher at the Liver Diseases - Viral Hepatitis Research group. Bachelor's degree in Biotechnology and MSc in Translational Biomedical Research by the Vall d'Hebron Institute of Research Fundation. Currently working as a PhD Student at the Liver diseases-Viral hepatitis research group and studying at the PhD program of Biochemistry, Molecular Biology and Biomedicine of Universitat Autònoma de Barcelona. My studies are focused on the evolution of viral quasispecies of SARS-CoV-2 in the most prevalent variants in Barcelona city over the pandemics, thanks to next generation sequencing (MiSeq and Nextseq2000 Illumina platforms), and how these viral quasispecies are involved with clinical and epidemiological purposes.

I studied a Biotechnology degree at the Rovira i Virgili University in Tarragona, Spain. I followed my training during an internship at the Liver Diseases - Viral Hepatitis from VHIR, leaded by Dr. Josep Quer. Finally, I did the TFG in collaboration with Dr. Quer's group which was named "Características genéticas y variabilidad del SARS-CoV-2, agente causal de la COVID-19"

Afterwards, I studied the Traslational Biomedical Research Master by the VHIR and the Universitat Autònoma de Barcelona (UAB), where I worked as liscenced technician at the Liver Diseases - Viral Hepatitis research group. During this internship at Vall d'Hebron, I wrote my TFM named as "SARS-CoV-2: study of solubility of spike truncated protein (S1) and ongoing viral adaptation in new emerging variants". Furthermore, I worked as an active participant in several competitive projects related to the genomic study of Hepatitis C Virus (HCV) and SARS-CoV-2 variability.


Currently I keep working at the VHIR as PhD student of the Biochemistry, Molecular Biology and Biomedicine PhD Program from the UAB at the Liver Diseases - Viral Hepatitis research group. My PhD thesis is focused on the study of expression, localization and solubility in cell culture of the spike truncated protein of SARS-CoV-2 formed merely by the subunit 1. In addition to the in vitro research, I also study the variability of S gen in different SARS-CoV-2 variants and the adaptation trough human population following the depp-sequencing methodology, thanks to Next Generation Sequencing (NGS) techniques.

Projects

Beca VHIR PhD

IP: Josep Quer Sivila
Collaborators: Sira Rodrigo Bosch, Laia Perez Lasarte, Carolina Campos Martinez
Funding agency: Fundació Institut de Recerca HUVH
Funding: 69188.74
Reference: VPHD/CAROLINA_C
Duration: 01/04/2023 - 31/03/2026

Estudio de quasispecies por metagenómica en neuropatías asociadas a virus por secuenciación masiva de nueva generación.

IP: Josep Quer Sivila
Collaborators: Sergi Colomer Castell, Lluís Viladomiu Catà, Damir Garcia Cehic, Maria Piñana Moro, Pablo Gabriel Medina, Arnau Llauradó Gayete, Carolina Campos Martinez, Alejandra Gonzalez Sánchez
Funding agency: Instituto de Salud Carlos III
Funding: 292820
Reference: PI22/00258
Duration: 01/01/2023 - 31/12/2025

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Victor Manuel Vargas Blasco, Maria Buti Ferret, Montserrat Gomez Perez, Torrens Buscató, Maria Margarita, Judit Vico Romero, Josep Quer Sivila, Adriana Palom Agusti, Juan Manuel Pericàs Pulido, Maria Nieves Martell Pérez-Alcalde, Damir Garcia Cehic, Daniel Martinez Vazquez, Laura Puente Ramo, Isabel Campos Varela, María Bermúdez Ramos, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Elena de Sena Fernández, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, Jesus Manuel Rivera Esteban, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano, Cesar Jimenez Hernandez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 31/12/2024

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Meritxell Ventura Cots

Meritxell Ventura Cots

Main researcher
Liver Diseases
Read more
Jessica  Aguilera  Garcia

Jessica Aguilera Garcia

Predoctoral researcher
Biomedical Research in Cancer Stem Cells
Read more
Andrea Garcia Garijo

Andrea Garcia Garijo

Predoctoral researcher
Read more
Irene Portas Torres

Irene Portas Torres

Research technician
Reconstructive Surgery of the Locomotor System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.